| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,666 |
7,221 |
$410K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,816 |
5,768 |
$369K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,388 |
3,237 |
$221K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,179 |
1,150 |
$131K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,393 |
1,363 |
$121K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
605 |
590 |
$42K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
599 |
588 |
$23K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
562 |
549 |
$22K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
356 |
353 |
$17K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,159 |
1,138 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,277 |
1,244 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
681 |
369 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
205 |
200 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
268 |
256 |
$5K |
| 99000 |
|
1,023 |
999 |
$5K |
| 99201 |
|
101 |
101 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
155 |
154 |
$3K |
| 81002 |
|
1,037 |
1,011 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
104 |
89 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
513 |
500 |
$531.82 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
425 |
423 |
$404.36 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
39 |
37 |
$368.98 |
| 73610 |
|
12 |
12 |
$307.06 |
| 99441 |
|
27 |
27 |
$205.92 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$190.84 |
| 81025 |
|
26 |
26 |
$171.12 |
| 36415 |
Collection of venous blood by venipuncture |
63 |
61 |
$151.20 |
| 99051 |
|
928 |
901 |
$33.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
65 |
65 |
$0.00 |
| 94760 |
|
915 |
868 |
$0.00 |